SCHEMBL5218678

SCHEMBL5218678

Cc1cccc(C)c1-n1cc(-c2nc3ccccc3o2)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 3/20 0.46
PTPN1 P18031 3/20 0.46
PTPN5 P54829 3/20 0.46
HSPD1 P10809 1/20 0.46
HSPE1 P61604 1/20 0.46
ALDH1A1 P00352 6/20 0.46
HSD17B10 Q99714 5/20 0.46
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
NPC1 O15118 8/20 0.45
KDM4E B2RXH2 5/20 0.45
HPGD P15428 5/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
TP53 P04637 2/20 0.45
RAB9A P51151 6/20 0.44
ATM Q13315 1/20 0.44
HCRTR1 O43613 2/20 0.44
MAPT P10636 2/20 0.44
USP2 O75604 1/20 0.44
TSHR P16473 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174671 0.81 ALDH1A1 (0.50) ALDH1A1HSD17B10MEN1KMT2ANPC1
SCHEMBL5217836 0.81 ALDH1A1 (0.50) ALDH1A1HSD17B10MEN1KMT2ANPC1
SCHEMBL5224725 0.81 NPC1 (0.47) PTPN2PTPN1PTPN5ALDH1A1HSD17B10
SCHEMBL5218794 0.80 NPC1 (0.48) PTPN2PTPN1PTPN5ALDH1A1HSD17B10
SCHEMBL5219184 0.78 RAB9A (0.44) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL5217963 0.78 NPC1 (0.46) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL5216455 0.78 NPC1 (0.42) PTPN2PTPN1PTPN5HSPD1HSPE1
SCHEMBL29000685 0.77 MET (0.64) ALDH1A1HSD17B10MEN1KMT2ANPC1
SCHEMBL5215815 0.76 GRM4 (0.54) ALDH1A1HSD17B10MEN1KMT2ANPC1
SCHEMBL5217080 0.76 NPC1 (0.45) ALDH1A1HSD17B10MEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458383-B1 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2007-11-21 EP claimed
EP-1458383-A4 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO INC (US) 2005-05-25 EP claimed
EP-1458383-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 Merck & Co., Inc. (US) 2004-09-22 EP claimed
WO-2004030637-A2 TREATMENT OF OBESITY AND OTHER DISORDERS ASSOCIATED WITH EXCESSIVE FOOD INTAKE MERCK & CO., INC. (US) 2004-04-15 WO claimed
WO-2003051833-A2 HETEROARYL SUBSTITUTED PYRAZOLE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR-5 MERCK & CO., INC. (US) 2003-06-26 WO claimed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 US disclosed
US-7569592-B2 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5 MERCK & CO., INC. (US) 2009-08-04 US disclosed